LeMaitre Vascular, Inc. (LMAT) Misses Q2 EPS by 5c, Cuts FY11 Sales Guidance, Declares Dividend
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $82.53 +0.18%
Financial Fact:
Income from operations: 5.34M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income from operations: 5.34M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
LeMaitre Vascular, Inc. (NASDAQ: LMAT) reported Q2 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $15.1 million versus the consensus estimate of $15.05 million.
LeMaitre Vascular, Inc. sees Q3 2011 revenue of $14.6 million, versus the consensus of $14.7 million. Operating income for the quarter is expected to be $1.5 million.
The Company is reducing its full-year 2011 sales guidance by $2.3mm due in large part to its exit from stent grafts. Full-year operating income guidance is after approximately $2.0mm of charges and special items associated with the five strategic initiatives detailed below.
The Company's Board of Directors approved the payment of a quarterly cash dividend on the Company's common stock of $0.02 per share, with payment to be made on September 6, 2011 to shareholders of record at the close of business on August 19, 2011
LeMaitre Vascular, Inc. sees Q3 2011 revenue of $14.6 million, versus the consensus of $14.7 million. Operating income for the quarter is expected to be $1.5 million.
The Company is reducing its full-year 2011 sales guidance by $2.3mm due in large part to its exit from stent grafts. Full-year operating income guidance is after approximately $2.0mm of charges and special items associated with the five strategic initiatives detailed below.
The Company's Board of Directors approved the payment of a quarterly cash dividend on the Company's common stock of $0.02 per share, with payment to be made on September 6, 2011 to shareholders of record at the close of business on August 19, 2011
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- InspireMD (NSPR) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Dividends, Earnings, GuidanceRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
